recent articles
Cancer is the second leading cause of death worldwide, with nearly 10 million deaths annually.1,2 In the U.S., approximately 1.9 million new cancer cases are expected to be diagnosed in 2021.1 Based on cancer biomarkers, the...
25 years ago when I started my clinical rotations as a third-year medical student, my interest in pathology across the medical and surgical specialties was usually met with a question such as "Why do you want to do pathology? You are going to...
Last month the FDA approved pembrolizumab (KEYTRUDA) for adult and pediatric patients with with metastatic or unresectable, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors that have...
© 2023 Tissuepathology.com. All rights reserved. Millennial Consulting. | Web Design by Zealth Digital Marketing